Trial Profile

Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-naive Patients With Type 2 Diabetes Treated With Metformin and Not Adequately Controlled.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine (Primary) ; Sitagliptin (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms EASIE
Sponsors Sanofi

Most Recent Events

12 Jun 2012 Results published in the Lancet.
09 Jun 2012 Results were reported at the 72nd Scientific Sessions of the American Diabetes Association, and in a Sanofi media release.
03 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov (Parent trial: NCT00751114).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com